Superoxide dismutase activity and zinc and copper concentrations in Parkinson's disease

Pathophysiology

Volumn 7, Issue 1, 2000, Pages 63-67

  Kocatürk, Pelin Aribal ^a   Akbostanci, M Cenk ^a   Tan, Funda ^a   Kavas, Güzin Özelçi ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Copper; Parkinson's disease; Red cell superoxide dismutase; Zinc

Indexed keywords

COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; ZINC;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 2542507566     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4680(00)00030-4     Document Type: Article

References (16)

1. Olanov C.W., Arendash G.V. Metals and free radicals in neurodegeneration. Curr. Opin. Neurol. 7:1994;548-558.
2. Kondo T. Parkinson's disease and free radicals. Ann. NY Acad. Sci. 786:1996;206-216.
3. Jenner P. Oxidative damage in neurodegenerative disease. Lancet. 344:1994;796-798.
4. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32:1992;804-812.
5. Pall H.S., Williams A.C. Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet. 2:1987;238-241.
6. Kushner L. Regulation of the acute phase response by cytokines. Perspect. Biol. Med. 36:1993;611-622.
7. Winterbourn C.C., Hawkins R.E., Brain M. The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med. 85:1975;337-341.
8. Perkin E. Analysis of serum determination of copper and zinc (BC-8). Analytical Method for Atomic Absorption Spectrophotometry. 1973;Perkin-Elmer, Norwalk, Connecticut.
9. Lohr J.B. Oxygen radicals and neuropsychiatric illness. Arch. Gen. Psych. 48:1991;1097-1106.
10. Yoshida E., Mokuno K., Aoki S.I. Cerebrospinal fluid levels of superoxide dismutases in neurological diseases detected by sensitivie enzyme immunoassays. J. Neurol. Sci. 124:1994;25-31.
11. Erausquin G.A., Costa E., Hanbauer I. Calcium homeostasis, free radical formation, and tropic factor dependence mechanisms in Parkinson's disease. Pharmacol. Rev. 46:1994;467-482.
12. Evans P.H. Free radicals in brain metabolism and pathology. Br. Med. B. 49:1993;577-587.
13. Swain J.A., Darley-Usmar V., Gutteridge J.M.C. Perxynitrite releases copper from caeruloplasmin: in implications for atherosclerosis. FEBS Lett. 342:1994;49-52.
14. Dexter D.T., Jener P., Schapira A.H.V., Marsden C.D. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann. Neurol. Suppl. 32:1992;S94-S100.
15. Loeffler D.A., LeWitt P.A., Juneau P.L. et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 738:1996;265-274.
16. Gupta J.B., Prasad M. Platelet-activating-factor-induced changes in cardiovascular function and oxyradical status of myocardium in presence of the PAF antagonist CV-6209. Angiology. 45:1994;25-36.